TuHURA Biosciences Total Liabilities and Share Holders Equity 2010-2024 | HURA

TuHURA Biosciences total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

TuHURA Biosciences Total Liabilities and Share Holders Equity 2010-2024 | HURA

TuHURA Biosciences total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$171.8B
Vertex Pharmaceuticals (VRTX)$122.6B
Gilead Sciences (GILD)$109.8B
Bristol Myers Squibb (BMY)$107B
Regeneron Pharmaceuticals (REGN)$106.1B
CSL (CSLLY)$96.1B
GSK (GSK)$78.8B
Alnylam Pharmaceuticals (ALNY)$38.1B
Argenex SE (ARGX)$34B
Biogen (BIIB)$27.1B
BioNTech SE (BNTX)$26.4B
Illumina (ILMN)$22.9B
BeiGene (BGNE)$21.5B
Moderna (MRNA)$20.5B
Genmab (GMAB)$15.1B
BioMarin Pharmaceutical (BMRN)$13.4B
Exact Sciences (EXAS)$13B
Insmed (INSM)$12.7B
Incyte (INCY)$12.6B
Vaxcyte (PCVX)$12.6B
Sarepta Therapeutics (SRPT)$12.2B
Bio-Techne Corp (TECH)$11.1B
QIAGEN (QGEN)$9.6B
Bio-Rad Laboratories (BIO.B)$9.3B
Roivant Sciences (ROIV)$8.7B
Exelixis (EXEL)$8.2B
Legend Biotech (LEGN)$8.2B
Intra-Cellular Therapies (ITCI)$8.1B
Repligen (RGEN)$8.1B
Revolution Medicines (RVMD)$7.9B